Active
SME

Aptus Pharma Ltd

Aptus Pharma Ltd IPO Details

Listing Date

30 Sep 2025

Bid Price

₹65 - ₹70

Lot Size

2000 Shares

Minimum Investment

₹2,80,000 / 2 Lots

Issue Size

₹13.02 Cr

Schedule

    Here are the important dates you need to know in order to participate in this IPO

tick

Offer Start Date

23rd Sep

tick

Offer End Date

25th Sep

tick

Allotment Date

26th Sep

tick

Refund Initiation

29th Sep

tick

Demat Transfer

29th Sep

tick

Listing Date

30th Sep

Aptus Pharma Ltd Shareholding Pattern

  Pre-Issue Post-Issue
Promoter Group 100% 72.89%
Public Group 0% 27.11%

Aptus Pharma Ltd IPO Reservation

QIB Shares Offered 3,52,000 (18.92%)
NII (HNI) Shares Offered 2,66,000 (14.3%)
Retail Shares Offered 6,20,000 (33.33%)
Anchor Investor Shares Offered 5,28,000 (28.39%)
Total Shares Offered 18,60,000
Total Shares With Anchor Investor 18,60,000

Aptus Pharma Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 2 4,000 ₹2,80,000
Retail (Max) 2 4,000 ₹2,80,000
S HNI (Min) 3 6,000 ₹4,20,000
S HNI (Max) 7 14,000 ₹9,80,000
B HNI (MIN) 8 16,000 ₹11,20,000

Aptus Pharma Ltd IPO Anchor Portion Size

Bid Date September 22, 2025
Shares Offered 5,28,000
Anchor Investment Details 3.696

Aptus Pharma Ltd IPO registrar

Bigshare Services Pvt Ltd
Phone Number 022-62638200
Email Id ipo@bigshareonline.com
Website www.bigshareonline.com

Aptus Pharma Ltd IPO Lead Manager

1. Interactive Financial Services Limited

Aptus Pharma Ltd Financial Information

March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹6.97 Cr ₹1.77 Cr ₹0.97 Cr
Reserves and Surplus ₹1.97 Cr ₹1.47 Cr ₹0.67 Cr
Total Borrowing ₹10.36 Cr ₹5.31 Cr ₹2.21 Cr

Aptus Pharma Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid Subscription (Times)
Qualified Institutional Buyers (QIBs) 3,52,000 4,36,000 1.2386
Non Institutional Investors (NIIs) 3,60,000 77,42,000 21.5056
Retail Individual Investors (RIIs) 6,20,000 1,95,52,000 31.5355
Total 13,32,000 2,77,30,000 20.82

Strength of Aptus Pharma Ltd

  • Diversified Product Portfolio.
  • Robust and Responsive Distribution Network.
  • Strategic Manufacturing Partnerships.
  • Commitment to High-Quality Standards.
  • Competitive and Cost-Effective Pricing.
  • Skilled and Committed Human Resources.
  • Experienced and Visionary Management Team.
  • Customer Satisfaction and Retention.

Risks Involved

  • The company does not have its own manufacturing facility for pharmaceutical products and the company have to relies on third parties for contract manufacturing of the products sold by the Company.
  • The company are required to obtain, renew or maintain certain material statutory and regulatory permits and approvals required to operate its business, and if the company fail to does so in a timely manner or at all, its may be unable to operate the company business and its results of operations may be adversely affected.
  • The company derive a significant part of the company revenue from few customers. If one or more of such customers choose not to source their requirements from the company or to terminate its contracts or purchase orders, the company business, cash flows, financial condition and results of operations may be adversely affected.
  • If the company are unable to protect its intellectual property rights, the company business, results of operations and financial condition may be adversely affected. Further, if its products were found to be infringing on the intellectual property rights of a third-party, the company could be required to cease selling the infringing products, causing the company to lose future sales revenue from such products and face substantial liabilities for infringement of intellectual property rights.
  • The Company may be exposed to product liability and other claims arising from defective medicines manufactured by third-party Contract Manufacturers, despite having manufacturing agreements in place, as indemnity terms are not pre-determined.
  • The company are highly dependent on the medical practitioners including general physicians, paediatricians, gynaecologists, cardiologists, endocrinologists, neurologists, and others. Any disruption in such understanding may adversely impact its business operations.
  • The company business is working capital intensive. If its are unable to borrow to meet the company working capital requirements, it may materially and adversely affect its business and results of operations.
  • The company have had negative cash flows from operating activities in the last three Fiscal years and may continue to have negative cash flows in the future which could have an impact on its business and operations.
  • The Company does not have intellectual property rights over its corporate logo. In absence of the company Registered Logo or Trademark there are chances of getting damage to its business prospects, reputation and goodwill and misuse of the company logo.
  • There have been certain delays in filing of GST, PF/ESIC returns of the company. Consequently, its may be subject to adverse regulatory actions and penalties for any past or future non-compliance and the company business, financial condition and reputation may be adversely affected.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Striders Impex Limited IPO
Bidding Period
26th Feb 2026 - 3rd Mar 2026
Price Range
₹71.0 - 72.0
IPO Size
₹36,29,00,000
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanta Enterprises Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amir Chand Jagadish Kumar Exports Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
APPL Containers Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ardee Engineering Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
GAUDIUM IVF AND WOMEN HEALTH LIMITED IPO
Bidding Period
20th Feb 2026 - 2nd Feb 2026
Price Range
₹75.0 - 79.0
IPO Size
₹1,65,00,00,000
MANILAM INDUSTRIES INDIA LIMITED IPO
Bidding Period
20th Feb 2026 - 2nd Feb 2026
Price Range
₹65.0 - 69.0
IPO Size
₹40,00,00,000
FRACTAL INDUSTRIES LIMITED IPO
Bidding Period
16th Feb 2026 - 2nd Feb 2026
Price Range
₹205.0 - 216.0
IPO Size
₹49,00,00,000
MARUSHIKA TECHNOLOGY LIMITED IPO
Bidding Period
12th Feb 2026 - 2nd Feb 2026
Price Range
₹111.0 - 117.0
IPO Size
₹27,00,00,000
FRACTAL ANALYTICS LIMITED IPO
Bidding Period
9th Feb 2026 - 2nd Feb 2026
Price Range
₹857.0 - 900.0
IPO Size
₹28,34,00,00,000
AYE FINANCE LIMITED IPO
Bidding Period
9th Feb 2026 - 2nd Feb 2026
Price Range
₹122.0 - 129.0
IPO Size
₹10,10,00,00,000
BIOPOL CHEMICALS LIMITED IPO
Bidding Period
6th Feb 2026 - 2nd Feb 2026
Price Range
₹102.0 - 108.0
IPO Size
₹31,00,00,000
PAN HR SOLUTION LIMITED IPO
Bidding Period
6th Feb 2026 - 2nd Feb 2026
Price Range
₹74.0 - 78.0
IPO Size
₹17,00,00,000
NFP SAMPOORNA FOODS LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹52.0 - 55.0
IPO Size
₹25,00,00,000
BRANDMAN RETAIL LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹167.0 - 176.0
IPO Size
₹86,00,00,000
GROVER JEWELLS LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹83.0 - 88.0
IPO Size
₹34,00,00,000
C K K RETAIL MART LIMITED IPO
Bidding Period
30th Jan 2026 - 2nd Feb 2026
Price Range
₹155.0 - 163.0
IPO Size
₹88,00,00,000
ACCRETION NUTRAVEDA LIMITED IPO
Bidding Period
28th Jan 2026 - 1st Jan 2026
Price Range
₹122.0 - 129.0
IPO Size
₹25,00,00,000
MSAFE EQUIPMENTS LIMITED IPO
Bidding Period
28th Jan 2026 - 1st Jan 2026
Price Range
₹116.0 - 123.0
IPO Size
₹66,00,00,000
KANISHK ALUMINIUM INDIA LIMITED IPO
Bidding Period
28th Jan 2026 - 1st Jan 2026
Price Range
₹73.0 - 73.0
IPO Size
₹29,00,00,000
KASTURI METAL COMPOSITE LIMITED IPO
Bidding Period
27th Jan 2026 - 1st Jan 2026
Price Range
₹61.0 - 64.0
IPO Size
₹18,00,00,000
HANNAH JOSEPH HOSPITAL LIMITED IPO
Bidding Period
22nd Jan 2026 - 1st Jan 2026
Price Range
₹67.0 - 70.0
IPO Size
₹42,00,00,000
SHAYONA ENGINEERING LIMITED IPO
Bidding Period
22nd Jan 2026 - 1st Jan 2026
Price Range
₹140.0 - 144.0
IPO Size
₹15,00,00,000
KRM AYURVEDA LIMITED IPO
Bidding Period
21st Jan 2026 - 1st Jan 2026
Price Range
₹128.0 - 135.0
IPO Size
₹77,00,00,000
SHADOWFAX TECHNOLOGIES LIMITED IPO
Bidding Period
20th Jan 2026 - 1st Jan 2026
Price Range
₹118.0 - 124.0
IPO Size
₹19,07,00,00,000
  • All
  • MainBoard
  • SME
MARUSHIKA TECHNOLOGY LIMITED IPO
Issue Prize
117.00
Listing Day Close
114.00(-2.56%)
FRACTAL ANALYTICS LIMITED IPO
Issue Prize
900.00
Listing Day Close
847.40(-5.89%)
AYE FINANCE LIMITED IPO
Issue Prize
129.00
Listing Day Close
128.90(0.00%)
BIOPOL CHEMICALS LIMITED IPO
Issue Prize
108.00
Listing Day Close
105.50(-1.85%)
PAN HR SOLUTION LIMITED IPO
Issue Prize
78.00
Listing Day Close
78.01(0.00%)
BRANDMAN RETAIL LIMITED IPO
Issue Prize
176.00
Listing Day Close
192.15(9.09%)
GROVER JEWELLS LIMITED IPO
Issue Prize
88.00
Listing Day Close
100.80(14.77%)
C K K RETAIL MART LIMITED IPO
Issue Prize
163.00
Listing Day Close
171.15(4.91%)
ACCRETION NUTRAVEDA LIMITED IPO
Issue Prize
129.00
Listing Day Close
191.20(48.06%)
MSAFE EQUIPMENTS LIMITED IPO
Issue Prize
123.00
Listing Day Close
150.30(21.95%)
KANISHK ALUMINIUM INDIA LIMITED IPO
Issue Prize
73.00
Listing Day Close
55.48(-24.66%)
KASTURI METAL COMPOSITE LIMITED IPO
Issue Prize
64.00
Listing Day Close
63.16(-1.56%)
HANNAH JOSEPH HOSPITAL LIMITED IPO
Issue Prize
70.00
Listing Day Close
68.25(-2.86%)
SHAYONA ENGINEERING LIMITED IPO
Issue Prize
144.00
Listing Day Close
151.00(4.86%)
KRM AYURVEDA LIMITED IPO
Issue Prize
135.00
Listing Day Close
180.70(34.07%)
SHADOWFAX TECHNOLOGIES LIMITED IPO
Issue Prize
124.00
Listing Day Close
109.90(-11.29%)
DIGILOGIC SYSTEMS LIMITED IPO
Issue Prize
104.00
Listing Day Close
79.05(-24.04%)
ARITAS VINYL LIMITED IPO
Issue Prize
47.00
Listing Day Close
44.65(-4.26%)
ARMOUR SECURITY INDIA LIMITED IPO
Issue Prize
57.00
Listing Day Close
43.35(-24.56%)
AM
AMAGI MEDIA LABS LIMITED IPO
Issue Prize
361.00
Listing Day Close
348.00(-3.60%)

Frequently Asked Questions

What is Aptus Pharma Ltd IPO?

Answer Field

Aptus Pharma Ltd IPO is a SME IPO of 18,60,000 equity shares of a face value of ₹10 aggregating up to ₹13.02 Crores. The issue is priced at ₹65 to ₹70 per share. The minimum order quantity is 2000 Shares. The IPO opens on September 23, 2025, and closes on September 25, 2025. Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE-SME.

When Aptus Pharma Ltd IPO will open?

Answer Field

The Aptus Pharma Ltd IPO opens on September 23, 2025 and closes on September 25, 2025.

What is the lot size of Aptus Pharma Ltd?

Answer Field

Aptus Pharma Ltd lot size is 2000 shares, and the minimum amount required is ₹2,80,000.

How to apply for Aptus Pharma Ltd IPO?

Answer Field

You can apply in Aptus Pharma Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Aptus Pharma Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Aptus Pharma Ltd IPO will be done on September 26, 2025, and the allotted shares will be credited to your demat account by September 29, 2025.

When is Aptus Pharma Ltd IPO listing date?

Answer Field

The Aptus Pharma Ltd listing date is September 30, 2025.

Who is the registrar of Aptus Pharma Ltd IPO?

Answer Field

The registrar of Aptus Pharma Ltd IPO is Bigshare Services Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Interactive Financial Services Limited will be the book-running lead manager of this IPO.

What is the fresh issue of Aptus Pharma Ltd IPO?

Answer Field

The fresh issue size is ₹13.02 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Aptus Pharma Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 2000 shares and ₹2,80,000 amount.

How can I approve the UPI mandate request for Aptus Pharma Ltd IPO?

Answer Field

To apply for Aptus Pharma Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Aptus Pharma Ltd?

Answer Field

The price of each Aptus Pharma Ltd share will be ranging in between ₹65 to ₹70 per share.

What is the cut-off time for the UPI mandate for Aptus Pharma Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, September 25, 2025.

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|